Deletion of the TNFAIP3/A20gene detected by FICTION analysis in classical Hodgkin lymphoma

BMC Cancer

Table 1 Patient characteristics

Case #	Diagnosis	Age (years)	Gender	Stage	B symptom	EBER-1
1	NS	28	F	II	-	-
2	NS	44	F	II	-	+
3	NS	30	M	I	-	-
4	NS	27	F	II	-	-
5	NS	18	F	II	-	-
6	NS	27	M	II	+	-
7	NS	22	M	IV	-	-
8	NS	57	M	III	-	-
9	NS	48	M	III		-
10	MC	29	M	IV	-	-
11	NS	34	M	II	-	-
12	NS	22	F	II	-	-
13	NS	14	F	I	-	-
14	MC	53	M	I	-	-
15	MC	59	M	I	-	+
16	MC	42	M	III	+	-
17	MC	50	M	II	-	-
18	MC	29	F	II	+	+
19	MC	50	M	I	-	+
20	NS	39	F	IV	-	-
21	NS	22	F	II	+	-
22	MC	55	F	I	-	+
23	LD	59	F	I	-	-
24	NS	32	F	II	+	-
25	NS	16	M	III	-	-
26	NS	24	F	III	-	-
27	NS	20	M	II	-	-
28	MC	67	F	IV	+	+
29	NS	26	F	II	-	-
30	MC	73	F	IV	-	+
31	MC	74	F	II	-	-
32	LR	81	F	II	-	-
33	MC	75	F	III	+	+
34	MC	33	F	III	+	-
35	MC	62	F	III	-	+
36	MC	53	M	II	-	+
37	LR	72	M	II	-	+
38	NS	16	F	II	-	-
39	NS	36	F	II	+	-
40	NS	16	F	II	-	-
41	LR	48	M	III	+	+
42	LD	67	M	I	-	+
43	NS	27	F	II	-	-
44	NS	43	F	II	-	-
45	NS	64	M	II	+	-
46	NS	66	F	III	-	+
47	NS	24	F	II	-	+

NS, Nodular sclerosis cHL; MC, Mixed cellularity cHL; LD, Lymphocyte-depleted cHL; LR, lymphocyte-rich cHL.

ISSN: 1471-2407

Case #	Diagnosis	Age (years)	Gender	Stage	B symptom	EBER-1
1	NS	28	F	II	-	-
2	NS	44	F	II	-	+
3	NS	30	M	I	-	-
4	NS	27	F	II	-	-
5	NS	18	F	II	-	-
6	NS	27	M	II	+	-
7	NS	22	M	IV	-	-
8	NS	57	M	III	-	-
9	NS	48	M	III		-
10	MC	29	M	IV	-	-
11	NS	34	M	II	-	-
12	NS	22	F	II	-	-
13	NS	14	F	I	-	-
14	MC	53	M	I	-	-
15	MC	59	M	I	-	+
16	MC	42	M	III	+	-
17	MC	50	M	II	-	-
18	MC	29	F	II	+	+
19	MC	50	M	I	-	+
20	NS	39	F	IV	-	-
21	NS	22	F	II	+	-
22	MC	55	F	I	-	+
23	LD	59	F	I	-	-
24	NS	32	F	II	+	-
25	NS	16	M	III	-	-
26	NS	24	F	III	-	-
27	NS	20	M	II	-	-
28	MC	67	F	IV	+	+
29	NS	26	F	II	-	-
30	MC	73	F	IV	-	+
31	MC	74	F	II	-	-
32	LR	81	F	II	-	-
33	MC	75	F	III	+	+
34	MC	33	F	III	+	-
35	MC	62	F	III	-	+
36	MC	53	M	II	-	+
37	LR	72	M	II	-	+
38	NS	16	F	II	-	-
39	NS	36	F	II	+	-
40	NS	16	F	II	-	-
41	LR	48	M	III	+	+
42	LD	67	M	I	-	+
43	NS	27	F	II	-	-
44	NS	43	F	II	-	-
45	NS	64	M	II	+	-
46	NS	66	F	III	-	+
47	NS	24	F	II	-	+

Case #	Diagnosis	Age (years)	Gender	Stage	B symptom	EBER-1
1	NS	28	F	II	-	-
2	NS	44	F	II	-	+
3	NS	30	M	I	-	-
4	NS	27	F	II	-	-
5	NS	18	F	II	-	-
6	NS	27	M	II	+	-
7	NS	22	M	IV	-	-
8	NS	57	M	III	-	-
9	NS	48	M	III		-
10	MC	29	M	IV	-	-
11	NS	34	M	II	-	-
12	NS	22	F	II	-	-
13	NS	14	F	I	-	-
14	MC	53	M	I	-	-
15	MC	59	M	I	-	+
16	MC	42	M	III	+	-
17	MC	50	M	II	-	-
18	MC	29	F	II	+	+
19	MC	50	M	I	-	+
20	NS	39	F	IV	-	-
21	NS	22	F	II	+	-
22	MC	55	F	I	-	+
23	LD	59	F	I	-	-
24	NS	32	F	II	+	-
25	NS	16	M	III	-	-
26	NS	24	F	III	-	-
27	NS	20	M	II	-	-
28	MC	67	F	IV	+	+
29	NS	26	F	II	-	-
30	MC	73	F	IV	-	+
31	MC	74	F	II	-	-
32	LR	81	F	II	-	-
33	MC	75	F	III	+	+
34	MC	33	F	III	+	-
35	MC	62	F	III	-	+
36	MC	53	M	II	-	+
37	LR	72	M	II	-	+
38	NS	16	F	II	-	-
39	NS	36	F	II	+	-
40	NS	16	F	II	-	-
41	LR	48	M	III	+	+
42	LD	67	M	I	-	+
43	NS	27	F	II	-	-
44	NS	43	F	II	-	-
45	NS	64	M	II	+	-
46	NS	66	F	III	-	+
47	NS	24	F	II	-	+

Case #	Diagnosis	Age (years)	Gender	Stage	B symptom	EBER-1
1	NS	28	F	II	-	-
2	NS	44	F	II	-	+
3	NS	30	M	I	-	-
4	NS	27	F	II	-	-
5	NS	18	F	II	-	-
6	NS	27	M	II	+	-
7	NS	22	M	IV	-	-
8	NS	57	M	III	-	-
9	NS	48	M	III		-
10	MC	29	M	IV	-	-
11	NS	34	M	II	-	-
12	NS	22	F	II	-	-
13	NS	14	F	I	-	-
14	MC	53	M	I	-	-
15	MC	59	M	I	-	+
16	MC	42	M	III	+	-
17	MC	50	M	II	-	-
18	MC	29	F	II	+	+
19	MC	50	M	I	-	+
20	NS	39	F	IV	-	-
21	NS	22	F	II	+	-
22	MC	55	F	I	-	+
23	LD	59	F	I	-	-
24	NS	32	F	II	+	-
25	NS	16	M	III	-	-
26	NS	24	F	III	-	-
27	NS	20	M	II	-	-
28	MC	67	F	IV	+	+
29	NS	26	F	II	-	-
30	MC	73	F	IV	-	+
31	MC	74	F	II	-	-
32	LR	81	F	II	-	-
33	MC	75	F	III	+	+
34	MC	33	F	III	+	-
35	MC	62	F	III	-	+
36	MC	53	M	II	-	+
37	LR	72	M	II	-	+
38	NS	16	F	II	-	-
39	NS	36	F	II	+	-
40	NS	16	F	II	-	-
41	LR	48	M	III	+	+
42	LD	67	M	I	-	+
43	NS	27	F	II	-	-
44	NS	43	F	II	-	-
45	NS	64	M	II	+	-
46	NS	66	F	III	-	+
47	NS	24	F	II	-	+